While the proportion of LY6D negative cases was larger in lymph node metastases in the MIBC cohort, the expression did not differ significantly between paired samples of lymph node metastases and primary tumours, neither in TURB nor in cystectomy specimens. The gene discussed is LY6D; the disease is metastatic malignant neoplasm in the lymph nodes.